毛细血管后肺高血压:临床综述
Joshua M Riley1, James J Fradin2, Douglas H Russ1
1Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19147, USA.
Journal of clinical medicine
|January 26, 2024
概括
毛囊后肺高血压 (PH),在左心病中很常见,源于左侧压力升高. 管理重点是治疗潜在的心脏病,以改善结果.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 毛囊后肺高血压 (PH),通常与左心病有关,是PH最常见的形式.
- 原因包括心力衰竭与保存的喷射分数,膜心脏病和与心房动相关的心房肌病.
- 左侧填充压力升高导致肺静脉拥堵和随后的PH.
研究的目的:
- 提供一篇关于毛细管后PH的综合性综述.
- 详细介绍其病因,病理生理学,诊断标准和管理策略.
- 为了突出其在先进心力衰竭的背景下其特定的相关性.
主要方法:
- 关于毛细血管后PH的现有文献的审查.
- 血液动力学定义和诊断工具的分析,如心声回声学.
- 对潜在心脏病的当前管理方法的综合分析.
主要成果:
- 血液动力学定义:平均肺动脉压>20 mmHg,肺血管阻力<3木单位,肺毛细血管压>15 mmHg.
- 慢性拥堵会导致肺动脉重塑,导致结合的毛细血管前后PH.
- 管理强调治疗主要的心脏问题,包括医学治疗,门干预和风险因素控制.
结论:
- 毛细血管后PH的有效管理取决于解决潜在的左心脏病.
- 向专业中心转诊可以改善患者的治疗结果.
- 在这种情况下,需要对肺动脉高血压的向治疗进行进一步的研究.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
180
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
180
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
167
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
167
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
182
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
182
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Pathogenesis and Clinical Features
274
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
274


